Browse Category

NASDAQ:RGC News 28 December 2025 - 2 February 2026

Regencell Bioscience stock price jumps again: RGC up 16% premarket after 40% surge

Regencell Bioscience stock price jumps again: RGC up 16% premarket after 40% surge

Regencell Bioscience shares jumped 16.3% to $35.77 in premarket trading Friday after a 40.4% surge Thursday, with no new company announcements. Thursday’s rally saw heavy volume and wide price swings, closing at $30.77. The company’s filings warn of “extreme price and volume fluctuations” and note it has no saleable products or revenue. Market cap reached about $15.2 billion as of Friday.
Regencell Bioscience (RGC) stock drops 20% in Nasdaq trade as volatility flares again

Regencell Bioscience (RGC) stock drops 20% in Nasdaq trade as volatility flares again

New York, Jan 13, 2026, 14:12 EST — Regular session Shares of Regencell Bioscience Holdings Limited dropped over 20% on Tuesday, continuing a volatile streak that has kept the Nasdaq-listed microcap in the spotlight on momentum trackers. The decline is significant because the stock has proven it can swing sharply with little notice, a pattern that can catch late buyers off guard and trigger rapid sell-offs when liquidity dries up. The spotlight returns to what usually moves this stock daily: price action and positioning, rather than a steady stream of news. Investors are asking less “what changed” and more “how
Regencell Bioscience (RGC) stock swings 45% then closes up 10.6% — what to watch Monday

Regencell Bioscience (RGC) stock swings 45% then closes up 10.6% — what to watch Monday

New York, Jan 11, 2026, 08:22 EST — Market closed. Regencell Bioscience Holdings Ltd shares closed Friday up 10.6% at $45.79, recovering sharply after dipping roughly 15% during the session. The Nasdaq-listed stock kicked off the day at $36.08 and swung between a low of $35.13 and a high of $50.92. U.S. markets were closed Sunday, leaving Monday to reveal if buyers will step back in as trading volume picks up—or if this rally will vanish just as fast as it appeared. The stock’s volatility unfolds amid legal and financial alarms. In its annual report filed Oct. 31, Regencell revealed
Why Regencell Bioscience (RGC) stock is moving today: choppy rebound after Nasdaq pauses

Why Regencell Bioscience (RGC) stock is moving today: choppy rebound after Nasdaq pauses

NEW YORK, Jan 9, 2026, 12:43 EST — Regular session Regencell Bioscience Holdings Limited shares rose about 8.5% to $44.96 in midday trading on Friday, clawing back from an early dip. The stock has swung between $35.13 and $50.92 in the session, with more than 1.1 million shares traded. The bounce keeps attention on RGC after a stretch of sharp moves that has been hard to pin on fresh company updates. Regencell’s investor-relations site shows its most recent press release was dated Oct. 31. (Regencell Bioscience –) Thursday was a reminder of how quickly the shares can turn: they ended
Regencell Bioscience (RGC) stock slides about 18% after five volatility halts on Nasdaq

Regencell Bioscience (RGC) stock slides about 18% after five volatility halts on Nasdaq

NEW YORK, January 8, 2026, 13:45 EST — Regular session Regencell Bioscience Holdings Limited shares were down 18.5% at $43.10 on Thursday, a sharp reversal after an early spike that pushed the Nasdaq-listed stock as high as $69.97. The shares opened at $62.00 and later fell to $36.01. The whipsaw matters because it comes on top of a two-day surge that has left little room for error. RGC jumped 60.1% on Wednesday and gained 22.2% on Tuesday, and it was still up about 30% from Tuesday’s close even after Thursday’s slide. The broader Nasdaq index was down about 0.6% on
Regencell Bioscience stock jumps 27% again as RGC’s wild swings draw momentum traders

Regencell Bioscience stock jumps 27% again as RGC’s wild swings draw momentum traders

New York, Jan 7, 2026, 10:56 EST — Regular session Regencell Bioscience Holdings Limited shares jumped about 27% to $41.90 in morning trading on Wednesday, extending a sharp two-day run for the Nasdaq-listed microcap. The stock has swung between $34.11 and $43.74 so far in the session, with nearly 1.0 million shares traded. Why it matters now: the move builds on Tuesday’s 22% gain and keeps Regencell near the top of the day’s high-volatility names, even by small-cap standards. The stock closed at $33.03 on Tuesday after trading as high as $35.68, following a $27.00 close on Monday. StockAnalysis The
Regencell Bioscience (RGC) stock jumps again: what to know behind the latest sharp swing

Regencell Bioscience (RGC) stock jumps again: what to know behind the latest sharp swing

New York, Jan 6, 2026, 12:38 (EST) — Regular session Regencell Bioscience Holdings Ltd shares rose 18.3% to $31.99 on Tuesday, after touching $34.40 earlier and sliding as low as $26.60. The Nasdaq-listed stock was last up $4.95 from Monday’s close of $27.04, with about 850,000 shares traded. The move keeps the Hong Kong-based bioscience company on momentum traders’ radar at the start of 2026, after a run of outsized daily swings. In small, lightly followed stocks, rapid price shifts can draw more short-term flow — and just as quickly reverse when liquidity thins. Regencell’s investor-relations site has not posted
Regencell Bioscience (RGC) stock slides nearly 5% in year-end trading as volatility persists

Regencell Bioscience (RGC) stock slides nearly 5% in year-end trading as volatility persists

NEW YORK, December 31, 2025, 11:51 ET — Regular session Regencell Bioscience Holdings Limited shares were down 4.8% at $21.79 as of 11:51 a.m. ET, after trading between $21.44 and $23.11 in a choppy session. The move came without any new company announcements. Regencell’s investor-relations site lists its most recent press release dated Oct. 31, and the latest SEC filing on EDGAR is its annual report filed the same day. Regencell Bioscience -+1 The pullback also tracked a softer tape across Wall Street on the final trading day of 2025, with trading volumes muted heading into the New Year’s holiday.
Regencell Bioscience stock jumps 11% as RGC volatility returns ahead of Tuesday’s open

Regencell Bioscience stock jumps 11% as RGC volatility returns ahead of Tuesday’s open

NEW YORK, December 30, 2025, 05:20 ET — Premarket Regencell Bioscience Holdings Ltd shares were last indicated at $23.48 in off-hours trade ahead of Tuesday’s U.S. session. The stock ended Monday up 10.96% at $23.48, after trading as low as $19.80 and as high as $25.50, with about 723,000 shares changing hands, MarketBeat data showed. Market capitalization was listed at roughly $11.6 billion. MarketBeat The move stood out on a day when U.S. stocks finished lower, leaving investors cautious heading into a holiday-shortened stretch. Thin liquidity can exaggerate price swings in smaller, headline-sensitive names. Reuters Regencell itself has not posted
Regencell Bioscience Holdings Limited (NASDAQ: RGC) Stock: Shares Slide Into the Weekend After a 14% Drop—What to Watch Before Monday’s Open

Regencell Bioscience Holdings Limited (NASDAQ: RGC) Stock: Shares Slide Into the Weekend After a 14% Drop—What to Watch Before Monday’s Open

NEW YORK, Dec. 28, 2025, 3:41 a.m. ET — Market closed (weekend). Regencell Bioscience Holdings Limited (NASDAQ: RGC) heads into the weekend with traders focused on one thing: volatility. RGC stock finished the last regular session (Friday) sharply lower, while the broader market logged weekly gains in a quiet, holiday-shortened week—setting up a potentially jumpy start to the next session when U.S. equities reopen on Monday, Dec. 29. Investopedia RGC stock price today: where Regencell Bioscience stands after Friday’s slide RGC shares closed Friday at $21.16, down $3.44 (-13.98%) on the day. Trading was wide, with an intraday range of

Stock Market Today

Wesfarmers share price: what to watch on ASX next week as results loom

Wesfarmers share price: what to watch on ASX next week as results loom

7 February 2026
Wesfarmers shares closed down 1.33% at A$85.04 on Friday, following a sharp drop in the S&P/ASX 200, which fell 2% for its steepest one-day loss in 10 months. Investors are watching for Australia’s household spending data next week and Wesfarmers’ half-year results due Feb. 19.
Go toTop